Sangamo Therapeutics Inc (NASDAQ:SGMO) shares, rose in value on Thursday, January 02, with the stock price up by 10.78% to the previous day’s close as strong demand from buyers drove the stock to $1.13.
Actively observing the price movement in the last trading, the stock closed the session at $1.02, falling within a range of $0.9702 and $1.14. Referring to stock’s 52-week performance, its high was $3.18, and the low was $0.30. On the whole, SGMO has fluctuated by -52.12% over the past month.
With the market capitalization of Sangamo Therapeutics Inc currently standing at about $235.77 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SGMO’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of SGMO currently trading nearly -47.36% and -46.29% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 33.21, while the 7-day volatility ratio is showing 16.26% which for the 30-day chart, stands at 14.30%. Furthermore, Sangamo Therapeutics Inc (SGMO)’s beta value is 1.30, and its average true range (ATR) is 0.35.
A comparison of Sangamo Therapeutics Inc (SGMO) with its peers suggests the former has fared considerably weaker in the market. SGMO showed an intraday change of 10.78% in last session, and over the past year, it grew by 103.13%%.
Data on historical trading for Sangamo Therapeutics Inc (NASDAQ:SGMO) indicates that the trading volumes over the past 10 days have averaged 13.93 and over the past 3 months, they’ve averaged 9.34 million. According to company’s latest data on outstanding shares, there are 208.62 million shares outstanding.
Nearly 4.54% of Sangamo Therapeutics Inc’s shares belong to company insiders and institutional investors own 27.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 19.61 million shares as on 2024-12-13, resulting in a short ratio of 3.54. According to the data, the short interest in Sangamo Therapeutics Inc (SGMO) stood at 945.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 13.39 million. The stock has risen by 10.78% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SGMO stock heading into the next quarter.
